Company / SG&A per Share
BeOne Medicines Ltd. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.50
FY2025
5-year range
$0.82 / $1.50
FY2021-FY2025
Trend
+11.4%
vs FY2024
Sector context
#98 of 210
Health Care
What the data says
At $1.50, BeOne Medicines Ltd.'s sg&a per share ranks #113 of 210 in the Health Care sector. SG&A per Share has increased for 8 consecutive years, from $0.12 in FY2017 to $1.50 in FY2025.
Based on SEC 10-K filings.
1.50 in FY2025 with a 5-year CAGR of +14.9%.
Increased from $1.11 to $1.50 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +16.1%
- 5-Year CAGR
- +14.9%
- 10-Year CAGR
- -
Sector benchmark
#113 of 210 in Health CareTop 53% of 210This company $1.50 Sector average $29.50
▼
-94.9% below sector average
Key checks
Key Insights
- BeOne Medicines Ltd.'s sg&a per share has grown for 8 consecutive years.
- In FY2025, sg&a per share increased 11.4% year-over-year.
- Ranks #98 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.50 | +11.4% |
| FY2024 | $1.35 | +21.1% |
| FY2023 | $1.11 | +16.1% |
| FY2022 | $0.96 | +16.7% |
| FY2021 | $0.82 | +9.6% |
| FY2020 | $0.75 | +49.7% |
| FY2019 | $0.50 | +51.6% |
| FY2018 | $0.33 | +171.9% |
| FY2017 | $0.12 | -29.8% |
| FY2016 | $0.17 | +161.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026